Melanoma Research

Papers
(The H4-Index of Melanoma Research is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan31
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study30
Rurality as a predictor of melanoma stage and treatment in Indiana: a retrospective cohort study23
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors22
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?19
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread18
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases18
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases17
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting16
Study of clinical characteristics and risk factors for amelanotic/hypomelanotic melanoma in an Australian cohort15
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel15
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model14
Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection14
0.086388111114502